NCT06972719View on ClinicalTrials.gov

Hormone Replacement Therapy After Risk Reducing Salpingo-oophorectomy

NARecruitingINTERVENTIONAL

Enrollment

50

Participants

Timeline

Start Date

September 30, 2025

Primary Completion Date

July 1, 2026

Study Completion Date

December 31, 2026

Conditions

BRCA1 MutationBRCA2 Mutation

Interventions

BEHAVIORAL

Experimental Arm

Participants will be randomized to SOC plus the video.

BEHAVIORAL

SOC Arm

Participants will be randomized to SOC counseling.

Trial Locations (1)

27710

RECRUITING

Duke University Health System, Durham

Sponsors

Lead Sponsor

Duke University

All Listed Sponsors

lead

Duke University

OTHER